null

Phospho-Paxillin-Y118 Antibody (CABP0156)

SKU:
CABP0156
Product Type:
Antibody
Applications:
WB
IHC
Reactivity:
Human
Mouse
Rat
Host Species:
Rabbit
Isotype:
IgG
Research Area:
Cell Biology
  • Cell Biology Antibodies 16 Anti-Phospho-Paxillin-Y118 Antibody CABP0156
  • Cell Biology Antibodies 16 Anti-Phospho-Paxillin-Y118 Antibody CABP0156
  • Cell Biology Antibodies 16 Anti-Phospho-Paxillin-Y118 Antibody CABP0156
€159
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

Anti-Phospho-Paxillin-Y118 Antibody (CABP0156)

The Phospho-Paxillin (Y118) Polyclonal Antibody (CABP0156) is a valuable tool for researchers studying signaling pathways involved in cell adhesion and migration. Paxillin is a focal adhesion adaptor protein that plays a crucial role in linking integrin signaling to actin cytoskeleton dynamics. This antibody, raised in rabbits, specifically targets phospho-Paxillin at tyrosine 118, a critical phosphorylation site involved in regulating the function of Paxillin.The Phospho-Paxillin (Y118) Polyclonal Antibody is highly reactive with human samples and has been validated for use in Western blot applications. By targeting the phosphorylated form of Paxillin, researchers can investigate the activation status of Paxillin in response to various stimuli and conditions. This antibody enables the detection and analysis of phospho-Paxillin in different cell types, allowing for a better understanding of its role in cell migration, invasion, and adhesion processes.

Studies have shown that phosphorylation of Paxillin at Y118 is associated with increased cell motility and invasion in cancer cells, suggesting its potential importance in cancer progression and metastasis. Additionally, dysregulation of Paxillin signaling has been implicated in various other diseases, including cardiovascular disorders and inflammatory conditions. Understanding the regulatory mechanisms of phospho-Paxillin Y118 is essential for developing targeted therapies that can modulate cell adhesion and migration in disease states.Overall, the Phospho-Paxillin (